Referenzen und Publikationen zum In-Check Nasal (PNIF) und Youlten (PNIF)

In nachstehenden Referenzen wurden In-Check Nasal (PNIF) und Youlten (PNIF) im Text zitiert, entweder namentlich oder durch Funktion, oder es waren relevante Informationen zur Verwendung der Geräte enthalten. Das Format der Referenzen ist wie folgt: Autor(en), Titel, wo publiziert, Datum, Referenzdetails:

Autor(en), Titel, wo publiziert, Datum, Referenzdetails:

  1. Badia Lydia, Lund Valerie. Topical Corticosteroids in Nasal Polyposis. Drugs 2001; 61 (5).
  2. Bittera I, Kadocsa E, Elek A, Tegzes E, Menczel L, Tekulics P. Comparison of budesonide and fluticasone nasal sprays in the treatment of children with allergic rhinitis. Allergy 2000, Supplement 63, Volume 55, Abstract no. 649, 2000
  3. Briscoe M.P., Day J.H., Rafeiro E., Pettersson E. Akerlund A. #1134 Onset of Action of Intranasal Budesonide (Rhinocort® Aqua) in Seasonal Allergic Rhinitis (SAR) Studied in a Controlled Exposure Model.
  4. Cho S. MD; Hauser R., MD,ScD, MPH; Christiani D., MD, MPH, FCCP. Reproducibility of Nasal Peak Inspiratory Flow Among Healthy Adults. Chest/112/6/ December 1997.
  5. Da Graca Castel-Branco M, Bende N, Carrillo T, Vòna I, Arheden L. Budesonide Aqueous Nasal Spray (BANS) Compared to Mometasone Furoate (MF) in Patients with Perennial Allergic Rhinitis. Allergy 2000, Supplement 63, Volume 55, Abstract 665, 2000.
  6. Da Graca Castel-Branco M, Stahl E, Svensson K, Bende M, Carillo T, Vòna I, Arheden L. Health-Related Quality of Life, Assessed by a Generic Questionnaire (SF-36), Improved in Budesonide Aqueous Nasal Spray Treated Patients with Perennial Allergic Rhinitis. Allergy 2000, Supplement 63, Volume 55, Abstract 671, 2000.
  7. Day JH etal. Onset of activity of Rhinocort using the Youlton. J. Allergy & Clin. Immunol 2000 105:489-94
  8. Day JH, Briscoe MP, Rafeiro E, Ellis AK, Pettersson E, Akerlund A. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol 2000 Mar; 105(3):489-94
  9. Dempsey O.J, Wilson A.M, Sims E.J, Lipworth B.J. A Comparison of Once Daily Topical Budesonide (BUD) and Oral Montelukast (MON) in Seasonal Allergic Rhinitis (SAR) and Asthma. European Respiratory Journal, Volume 14, Supplement 30, October 1999
  10. Depledge MH. Peak inspiratory flow: measurement using a modified mini Wright peak flow meter. Thorax 1985 Mar;40(3):205-6.
  11. Dessanges J.F., Test de provocation nasale (TPN). Fiche Technique no. 14.
  12. Didour M.D, Jurkov I.V, Sinitcina T.M, Pravosudov V.P, Titova O.N, Suchneva L.V. Efficacy of nasal force inspiratory maneuver in asthmatic patients. The European Respiratory Society 2000, Italy ERJ Volume 16, S31, 1s-658s.
  13. Fokkens W.J, Cserhati E, dos Santos JML, Hosszu Z. Efficacy of Budesonide Aqueous Nasal Spray (Rhinocort® Aqua) in Children with Perennial Allergic Rhinitis. AAAAI, 56th Annual Meeting. Abstract No 1145, 1999
  14. Fokkens W, Pinto R, Cserhàti E, Praca F, van Zanten M, Schade A, Simon G, Pettersson E. Budesonide Aqueous Nasal Spray in Children with Perennial Allergic Rhinitis. Allergy 2000, Supplement 63, Volume 55, Abstract 131, 2000
  15. Ghaem A., Dessanges J.P., Lockhart A., Martineaud J.P. Exploration Par Rhinomanometrie des maladies atteints d'allergie respiratoire. Bull. Eur. Physiopathol. Respir 1986, 22, 443-449
  16. Gleeson M.J, Youlten L.J.F, Shelton D.M, Siodlak M.Z, Eiser N.M and Wengraf C. Assessment of Nasal Airway Patency: A comparison of four methods. Clin. Otolaryngol. 1986, 11, 99-107
  17. Hallen H, Enerdal J, Graf P. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa, Clin. Exp Allergy 1997 May 27(5): 552-8
  18. Hellgren J, Jarlstedt J, Dimberg L, Torén K, Karlsson G. A Study of Some Current Methods for Assessment of Nasal Obstruction. European Respiratory Journal 1996, Vol 9, S23 (0203), 18s.
  19. Holmberg K, MD, PhD, Juliusson S MD, PhD, Balder, Smith D L, Richards DH, Karlsson G MD, PhD. Flucticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Annals of Allergy, Asthma & Immunology Vol. 78, Number 3, March 1997.
  20. Holmström M., Scadding G.K, Lund V.J and Darby Y.C. Assessment of Nasal Obstruction. A comparison between rhinomanometry and nasal Inspiratory peak flow. Rhinology, 28, 191-196, 1990
  21. Holmstrom M. Clinical performance of fluticasone propionate nasal drops. Allergy 1999;54 Suppl 53:21-5
  22. Jankowski R. MD; Schrewelius, DDS; Bonfils P., MD; Saban Y.MD; Gilain L, MD; Prades J-M., MD; Strunski V., MD. Efficacy and Tolerability of Budesonide Aqueous Nasal Spray Treatment in Patients with Nasal Polyps.
  23. Jordana G, Dolovich J, Briscoe MP, Day JH, Drouin MA, Gold M, Stepner N, Yang W. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patient with seasonal allergic rhinitis. J Allergy Clin Immunol 1996 Feb. 97 (2): 588-95.
  24. Keith P., Nieminen J., Hollingworth K., Dolovich J. Efficacy and tolerability of flicasone propionate nasal drops 400mcg once daily compared with placebo for the treatment of bilateral polyposis in adults. Clinical and Experimental Allergy, 2000, volume 30, pages 1460-1468.
  25. Landwehr L.P., Vandewalker M.L., Stricker W.E. A Pilot Study of the Effect of Tropical Nasal Peak Inspiratory Flow Rate in Allergic Rhinitis. Poster Annual Meeting-American College of Allergy, Asthma & Immunology.
  26. Larsen K., Oxhoj H., Grontved A., Kristensen S. Peak flow nasal patency indices in patients operated for nasal obstruction, European Archives of Otorhinolaryngol (1990) 248: 21-24.
  27. Lund Valerie J.MD; Flood Joanne, RSN; Andrew P Sykes, BSc; David H. Richards, BSc. Effect of Fluticasone in Severe Polyposis. Archibes of Otolaryngology - Head & Neck Surgery May 1998 Volume 124.
  28. Mackay I.S., Durham S.R. Perennial rhinitis. BMJ 1998;316:917 (21 March).
  29. Mastalerz L, Milewski M, Duplaga M, Nizankowska E, Szczeklik A. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin induced asthma. Allergy 1997 Sep;52(9):895-900
  30. Penttilä M., Poulsen P., Hollingworth K., Holmström M., Dose-related efficacy and tolerability or fluticasone propionate nasal drops 400 mcg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomised study in adult patients. Clinical and Experimental Allergy, 2000, Volume 30, Pages 94-102.
  31. Prescott C.A.J, Prescott K.E. Peak Nasal Inspiratory flow measurement: an investigation in children. International Journal of Pediatric Otorhinolaryngology 32 (1995) 137-141.
  32. Rowe-Jones Julian M. FRCS, Mackay Ian s., Management of nasal polyps. Current Opinion in Otolaryngology & Head and Neck Surgery 1998, 6:41-46.
  33. Taylor MA, Reilly D Llewellyn-Jones RH, McSharry C, Aitchison TC. Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 2000 Aug 19-26;321 (7259):471-6.
  34. Terrien MH, Rahm F, Fellrath JM, Spertini F. Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen. J Allergy Cin Immunol 1999 Jun; 103(6):1025-30
  35. Wihl J-A, Malm I., Rhinomanometry and nasal peak expiratory an inspiratory flow rate. Annals of Allergy, Volume 61, Juli 1988.
  36. Wilson A, Sims E, Coutie W, Lipworth B. Domiciliary Nasal Flow Is A Better Marker of Treatment Response Than Rhinomanometry or Acoustic Rhinometry in Patients With Allergic Rhinitis and Asthma. AAAAI 56th Annual Meeting. Abstract No 609, 1999
  37. Wilson A, Dempsey O.J, Sims E.J, Coutie W.J.R, Patterson M.C, Lipworth B.J. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clinical and Experimental Allergy, 2000, Volume 30, pages 833-838.
  38. Wilson A.M, Dempsey O.J, Sims E.J, Lipworth B.J. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2000 Aug; 85 (2):111-4.
  39. Wilson A.M, Orr L.C, Sims E.J, Lipworth B.J. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clinical and Experimental Allergy, 2001, Volume 31, pages 61-68.
  40. Wilson A.M, Dempsey O.J, Sims E.J, Lipworth B.J. A comparison of tropical budesonide and oral montelukast in allergic rhinitis and asthma. Clin Exp. Allergy 2001 Apr; 31 (4):616-24
  41. Wilson A.M., Orr L.C., Coutie W.J.R., Sims E.J., Lipworth B.J. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clin Exp All 202; 32:126-132
  42. Wilson AM, White PS, Gardiner Q, Nassif R, Lipworth BJ. Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting. Rhinology 2001 Sep;39 (3): 142-6
  43. Wilson AM, Sims EJ, Orr LC, Coutie WJ, White PS, Gardiner Q, Lipworth BJ. Effects of topical corticosteroid and combined mediator blockade on domiciliary andlaboratory measurements of nasal function in seasonal allergic rhinits. Ann Allergy Asthma Immunol 2001 Oct;87 (4);344-9.
  44. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2000 Aug; 85(2):87-8
  45. Youlton L.J.F., Nasal Airway Patency Measurement in the Assessment of Rhinitis Therapy.
  46. Youlton L.J.F., The Peak Nasal Inspiratory Flow Meter: A new instrument for the assessment of the response to immunotherapy in seasonal allergic rhinitis. Allergol Immunopathol, 1980 8 (344).
  47. Zoest Van J.G., Weij van der A.M., Duiverman E.J., Akerlund A, Kouwenberg JM. Nasal peak inspiratory flow through turbuhaler in children with symptomatic rhinitis and in healthy children. Pediatr Allergy Immunol 2000 Nov; 11(4): 256-9
  48. Bergmüller CH. MD, Kirsche H.P. MD, Rettinger G. MD, PhD, Riechelmann H. MD, PhD Diagnostic Accuracy of Peak Nasal Inspiratory Flow and Rhinomanometry in Functional Rhinosurgery. The Laryngoscope 118: XX 2008